Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR2554 and Liposomal Mitoxantrone in First-line PTCL
NCT07725705Phase 2Not yet recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2028
01
Overview
A Phase 2 trial of zeprumetostat in peripheral T-cell lymphoma (PTCL), sponsored by Institute of Hematology and Blood Diseases Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
zeprumetostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT07725705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07725705.